The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

Biologics have transformed the treatment of immune-mediated inflammatory diseases such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). Biosimilars—biologic medicines with no clinically meaningful differences in safety or efficacy from licensed originators—can stimulate market comp...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drugs
Hoofdauteurs: Kim, HoUng, Alten, Rieke, Avedano, Luisa, Dignass, Axel, Gomollón, Fernando, Greveson, Kay, Halfvarson, Jonas, Irving, Peter M., Jahnsen, Jørgen, Lakatos, Péter L., Lee, JongHyuk, Makri, Souzi, Parker, Ben, Peyrin-Biroulet, Laurent, Schreiber, Stefan, Simoens, Steven, Westhovens, Rene, Danese, Silvio, Jeong, Ji Hoon
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer International Publishing 2020
Onderwerpen:
Leading Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007415/
https://ncbi.nlm.nih.gov/pubmed/32002851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01256-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items